The impact of erlotinib use in non-small-cell lung cancer patients treated in a private reference general hospital and in a private cancer clinic from 2005 to 2011

OBJECTIVE: To report the demographic data and clinical outcomes of non-small-cell lung cancer patients exposed to erlotinib in any line of treatment. METHODS: This was a retrospective cohort study of nonsmall-cell lung cancer patients from a reference general hospital and a private oncology clinic,...

Descripción completa

Detalles Bibliográficos
Autores principales: Bognar, Cinthia Leite Frizzera Borges, Simon, Sergio Daniel, Gansl, Rene Claudio, Abramoff, Roberto, Aisen, Marcelo, Lopes, Gilberto de Lima, Smaletz, Oren, Peres, Stela Verzinhasse, Tabacof, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto de Ensino e Pesquisa Albert Einstein 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943812/
https://www.ncbi.nlm.nih.gov/pubmed/26154542
http://dx.doi.org/10.1590/S1679-45082015AO3326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943812/
https://www.ncbi.nlm.nih.gov/pubmed/26154542
http://dx.doi.org/10.1590/S1679-45082015AO3326

Ejemplares similares